Medicines Shares Up 24% After Court Asked US Patent And Trademark Office To Reconsider Extension Decision (MDCO)
Wednesday, March 17, 2010 - 14:19
Written on Wed, 03/17/2010 - 2:19pm
By Chip Brian

3/17/2010- Medicines (NASDAQ:MDCO) shares rose 24% to $10.26 after the company said that a court set aside a denial by the U.S. Patent and Trademark Office to the company's application to extend its pattern term for Angiomax.
The court asked the office to reconsider the matter.
According to a Reuters report, UBS analysts Maged Shenouda said, "We view this decision as positive for Medicines, as it potentially delays the launch of Angiomax competitors from entering the market."

Keywords: medicines

Ticker(s): MDCO

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.